Invesaro

Stocks Comparison

Lantheus vs Myriad Genetics: revenue, profit, margins and growth compared

Lantheus brought in $1.5B of revenue in fiscal 2025, Myriad Genetics $824.5M in fiscal 2025. Revenue changed by +0.5% at Lantheus and -1.6% at Myriad Genetics on the year before, so Lantheus grew faster. Lantheus kept 15.2% of its revenue as net profit, Myriad Genetics -44.4%.

Side by side, latest fiscal year

LNTHMYGN
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$1.5B$824.5M
Revenue growth+0.5%-1.6%
Net income$233.6M-$365.9M
Net margin15.2%-44.4%
Free cash flow$354.1Mn/a
Free cash flow margin23.0%n/a
Earnings per share (diluted)$3.41-$3.95
Cash$359.1M$149.6M
Debt$738K$119.9M
Price to earnings29.3n/a
Market value$6.5B$398.9M
Dividend yieldn/an/a
Rank by revenue in sector#118 of 523 · Health care#159 of 523 · Health care

Over the years

Revenue
LNTH FY2018: $343.4MLNTH FY2019: $347.3MLNTH FY2020: $339.4MLNTH FY2021: $425.2MLNTH FY2022: $935.1MLNTH FY2023: $1.3BLNTH FY2024: $1.5BLNTH FY2025: $1.5BMYGN FY2019: $851.1MMYGN FY2020: $638.6MMYGN FY2020: $557.1MMYGN FY2021: $690.6MMYGN FY2022: $678.4MMYGN FY2023: $753.2MMYGN FY2024: $837.6MMYGN FY2025: $824.5MFY18FY19FY20FY21FY22FY23FY24FY25
LNTH $1.5BMYGN $824.5M
Net income
LNTH FY2018: $40.5MLNTH FY2019: $31.7MLNTH FY2020: -$13.5MLNTH FY2021: -$71.3MLNTH FY2022: $28.1MLNTH FY2023: $326.7MLNTH FY2024: $312.4MLNTH FY2025: $233.6MMYGN FY2019: $4.6MMYGN FY2020: -$199.5MMYGN FY2020: -$223.6MMYGN FY2021: -$27.2MMYGN FY2022: -$112MMYGN FY2023: -$263.3MMYGN FY2024: -$127.3MMYGN FY2025: -$365.9MFY18FY19FY20FY21FY22FY23FY24FY25
LNTH $233.6MMYGN -$365.9M
Net margin
LNTH FY2018: 11.8%LNTH FY2019: 9.1%LNTH FY2020: -4.0%LNTH FY2021: -16.8%LNTH FY2022: 3.0%LNTH FY2023: 25.2%LNTH FY2024: 20.4%LNTH FY2025: 15.2%MYGN FY2019: 0.5%MYGN FY2020: -31.2%MYGN FY2020: -40.1%MYGN FY2021: -3.9%MYGN FY2022: -16.5%MYGN FY2023: -35.0%MYGN FY2024: -15.2%MYGN FY2025: -44.4%FY18FY19FY20FY21FY22FY23FY24FY25
LNTH 15.2%MYGN -44.4%
Revenue growth
LNTH FY2019: +1.2%LNTH FY2020: -2.3%LNTH FY2021: +25.3%LNTH FY2022: +119.9%LNTH FY2023: +38.6%LNTH FY2024: +18.3%LNTH FY2025: +0.5%MYGN FY2020: -25.0%MYGN FY2020: -12.8%MYGN FY2021: +24.0%MYGN FY2022: -1.8%MYGN FY2023: +11.0%MYGN FY2024: +11.2%MYGN FY2025: -1.6%FY19FY20FY21FY22FY23FY24FY25
LNTH +0.5%MYGN -1.6%
Free cash flow
LNTH FY2018: $41.1MLNTH FY2019: $58.3MLNTH FY2020: $16.4MLNTH FY2021: $53.9MLNTH FY2022: $21.8MLNTH FY2023: $259.9MLNTH FY2024: $493.1MLNTH FY2025: $354.1MMYGN FY2019: $75.1MMYGN FY2020: $50.5MMYGN FY2021: $600KMYGN FY2022: -$151.6MFY18FY19FY20FY21FY22FY23FY24FY25
LNTH $354.1MMYGN -$151.6M

Fiscal years as each company reports them; the two may end in different months.

Questions about Lantheus and Myriad Genetics

Which is bigger by revenue, Lantheus or Myriad Genetics?

Lantheus is bigger by revenue: $1.5B in fiscal 2025, against $824.5M for Myriad Genetics in fiscal 2025.

Which keeps more of its revenue as profit, Lantheus or Myriad Genetics?

Lantheus had a net margin of 15.2% in fiscal 2025; Myriad Genetics had -44.4% in fiscal 2025.

Which grew revenue faster, Lantheus or Myriad Genetics?

In their latest fiscal years revenue changed by +0.5% at Lantheus and -1.6% at Myriad Genetics.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies